.jpg)
.png?width=2500&height=1100&name=SmartTabFeature%20(1).png)
Delivery systems that are being used today have not had drastic changes in hundreds of years. Leading some to argue, “why fix it if it’s not broken, right?” Well, that is the thing. It is broken, and it desperately needs fixing for the 21st century.
How are new technologies and ideas actually being developed to make the profound and clinically effective impact? Discover patient-centered innovation and the difference it can make for the healthcare field.
SmartTab is leading the drug delivery revolution in the digital medicine and digital therapeutics domain with three current patient-centric, technology enabled ingestible capsules under development.
.png?width=2500&height=1100&name=Crohns-Smarttab%20(2).png)
Over five million people in the U.S. suffer from Crohn’s Disease and Inflammatory Bowel Disease (IBD). Their conditions require targeted therapies, but that was almost impossible to come by until now.
Oral capsules and tablets have remained largely unchanged since their inception in the middle 1800s. Advancements in oral drug delivery technology has not kept pace with the medicine itself. Today, SmartTab is changing that.
SmartTab recognized a problem with medication delivery — it hasn’t changed in decades, but people have, schedules are busier, and people want less hassle. Patients have said for far too long, ‘there has to be a better way.’
A mountain-born medical revolution that will transform the pharmaceutical industry forever. Healthcare entrepreneur and visionary, Robert Niichel, is slowly making a name for himself as the “Grandfather of wireless drug delivery”.
Tina Aswani Omprakash, world-renowned health advocate, interviews CEO & CTO of SmartTab to understand the drug delivery platforms & how they can help improve quality of life for patients living with Crohn's or Ulcerative Colitis.
SmartTab is determined to limit the anxiety associated with managing diseases like Crohn’s & ulcerative colitis. Life with IBD can be a tough pill to swallow, but the future possibilities surrounding InjectTab may prove otherwise.
Denver's been booming in recent years & the pandemic hasn’t stopped the city’s growth. Colorado’s capital is poised to continue its climb as not only a national but international destination. There’s a spirit of fearlessness here.
Digital medicine is not science fiction any longer. It's evolving with a Denver-based startup & that day has come—injections with a conventional syringe & needle will be history very soon. SmartTab is a leader in digital medicine.
SmartTab's oral capsule for colon targeted drug delivery. Designed specifically for targeted delivery of medication. Successfully Completed PK Pre-clinical Animal Studies.
SmartTab's oral injection capsule for biologics and large molecules. Making injections with needles a thing of the past. Currently in the process of PK Pre-clinical Animal Studies.
SmartTab's multi-compartment capsule to reside in the stomach for a week with active ingredients to release each day. To begin PK Pre-clinical Animal Studies in 2022.
InjectTab™ is an oral delivery system for biologics and large molecules. A revolutionary wireless ingestible capsule designed to replace the conventional needle and syringe.
TargetTab™ is an ingestible capsule for wireless, targeted drug delivery. This is first application of the SmartTab Platform for Crohn's and other GI related diseases.
The TargetTab™ system utilizes inductive power (no on-board batteries) and proprietary innovative smart polymer technology for the actuation and release system. We continue to advance the capabilities of wireless power for the future of digital medicine.
The SmartTab platform connects with a smartphone or smartwatch via bluetooth RF signal to monitor when the capsule has reached the desired location. Monitoring for statistical based therapy optimization. Real-time decision making and wireless drug delivery.
We are developing superior drug delivery mechanisms. Using technology for an advanced drug delivery system that target's precise locations in the GI tract. When the triggering signal is sent, it releases immediately for better drug efficacy and better patient outcomes.
One of the biggest problems with treatments today is compliance. With the SmartTab electronic system triggering the release, the physician knows whether the patient is adhering to the prescribed drug treatment regimen.
By having a very specific targeted delivery system we can negate the negative side effects associated with the medicine and will be able to use lower dosages. Lower dosages means lower side effects and improved patient outcomes.
Integration with IoMT. Data can be sent into artificial intelligence and then optimize the treatment. The SmartTab platform will integrate with other systems as the future of digital health evolves.
SmartTab recently published “Advancing High Tech Drug Delivery Systems for the Treatment of Crohn’s Disease” in Inflammatory Bowel Diseases (IBD) Journal, and the Journal of Gastroenterology. A poster of distinction, as one of the top-scoring abstracts at the Crohn's and Colitis Congress 2021.
July 07, 2021
July 07, 2021
July 07, 2021
